GW Research Limited v. InvaGen Pharmaceuticals, Inc. et al > Summary

Court Case Number 1:23-cv-00256

Filing Date Jan 13, 2023

Termination Date Feb 16, 2023

Court New York Eastern District Court

Status Dismissed - Voluntarily

Doc No	Title	Issue date
11446258	Use of cannabinoids in the treatment of epilepsy	Sep 20, 2022
11357741	Use of cannabinoids in the treatment of epilepsy	Jun 14, 2022
11311498	Use of cannabinoids in the treatment of epilepsy	Apr 26, 2022
11207292	Cannabidiol preparations and its uses	Dec 28, 2021
11154516	Use of cannabinoids in the treatment of epilepsy	Oct 26, 2021
11096905	Use of cannabinoids in the treatment of epilepsy	Aug 24, 2021
10966939	Use of cannabinoids in the treatment of epilepsy	Apr 6, 2021
10849860	Use of cannabinoids in the treatment of epilepsy	Dec 1, 2020
10828310	Reducing the risk of cardiovascular events	Nov 10, 2020
10709671	Use of cannabinoids in the treatment of epilepsy	Jul 14, 2020
10709673	Use of cannabinoids in the treatment of epilepsy	Jul 14, 2020
10709674	Use of cannabinoids in the treatment of epilepsy	Jul 14, 2020
10603288	Use of cannabinoids in the treatment of epilepsy	Mar 31, 2020
10137095	Use of cannabinoids in the treatment of epilepsy	Nov 27, 2018
10111840	Use of cannabinoids in the treatment of epilepsy	Oct 30, 2018
10092525	Use of cannabinoids in the treatment of epilepsy	Oct 9, 2018
09956183	Use of cannabinoids in the treatment of epilepsy	May 1, 2018
09956184	Use of cannabinoids in the treatment of epilepsy	May 1, 2018
09956185	Use of cannabinoids in the treatment of epilepsy	May 1, 2018
09956186	Use of cannabinoids in the treatment of epilepsy	May 1, 2018
09949937	Use of cannabinoids in the treatment of epilepsy	Apr 24, 2018